SPARK scholars pivot to COVID-19 research
In the last year, current and former SPARK scholars have taken on 52 COVID-19 projects
Read PostIn the last year, current and former SPARK scholars have taken on 52 COVID-19 projects
Read PostScience Magazine asks, can a nose-full of chicken antibodies ward off coronavirus infections?
Read PostNasal drops containing antibodies are the result of an international collaboration coordinated by SPARK
Read PostDr. Santa Maria and team publish new disease model in Science Advances
Read PostSPARK Africa Director Prof. Collen Masimirembwa has been appointed chair of the Developing Countries Committee
Read PostSPARK scholar Shirit Einav and Sirle Saul summarize major repurposing approaches underway for COVID-19 in ACS Infect Dis
Read PostAs of April 2020, Dr. Rieko Yajima, SPARK’s Director of Drug Discovery Innovation, serves on the Selection Committee for the Global Health Innovative Technology (GHIT) Fund.
Read PostSPARK is one of four finalists for Xconomy's Ecosystem Development award
Read Post